Resverlogix’s Reprieve: ASSURE Results Suggest RVX-208 Works When Given With Crestor
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
While the ASSURE study failed overall, it turns out that a subset taking the HDL-raising drug candidate with the statin Crestor did benefit from treatment; Resverlogix is now planning to develop the combination.